scispace - formally typeset
R

Richard A. Flavell

Researcher at Yale University

Publications -  1389
Citations -  223064

Richard A. Flavell is an academic researcher from Yale University. The author has contributed to research in topics: Immune system & T cell. The author has an hindex of 231, co-authored 1328 publications receiving 205119 citations. Previous affiliations of Richard A. Flavell include National Institute for Medical Research & University of Michigan.

Papers
More filters
Journal ArticleDOI

Death of a Monopoly

TL;DR: Cavitation, an early developmental process in the mouse embryo that requires cell death, has now been suggested to occur through a caspase-independent pathway that instead uses a mitochondrial protein called AIF (apoptosis-inducing factor).
Journal ArticleDOI

BID-D59A Is a Potent Inducer of Apoptosis in Primary Embryonic Fibroblasts

TL;DR: This article showed that expression of a caspase-8 non-cleavable BID-D59A mutant or expression of wild type (wt) BID induces apoptosis.
Journal ArticleDOI

Teplizumab induces human gut-tropic regulatory cells in humanized mice and patients.

TL;DR: The findings demonstrate that humanized mice may be used to identify novel immunologic mechanisms that occur in patients treated with immunomodulators, and suggest mechanisms of drug action in murine models that have not been confirmed in clinical studies.
Journal ArticleDOI

m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity

TL;DR: In this article, the authors showed that ALKBH5 deficiency increased m6A modification on interferon-γ and C-X-C motif chemokine ligand 2 messenger RNA (mRNA), thus decreasing their mRNA stability and protein expression in CD4+ T cells.